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Abstract Amorphous silica nanoparticles (aSNPs) gain
increasing popularity for industrial and therapeutic claims.
The lung with its surface area of 100–140 m2 displays an
ideal target for therapeutic approaches, but it represents
also a serious area of attack for harmful nanomaterials. The
exact nature of the cytotoxic effects of NPs is still
unknown. Furthermore, cellular pathways and the destiny
of internalized NPs are still poorly understood. Therefore,
we examined the cytotoxicity (MTS, LDH) and inflam-
matory responses (IL-8) for different-sized aSNPs (30, 70,
300 nm) on our lung epithelial cells line NCI H441 and
endothelial cell line ISO-HAS-1. Additionally, colocaliza-
tion studies have been conducted via immunofluorescence
staining for flotillin-1- and flotillin-2-bearing endocytic
vesicles. Subsequently, the relevance of flotillins concern-
ing the viability of aSNP-exposed epithelial cells has been
evaluated using flotillin-1/2 depleted cells (siRNA). This
study reveals the relevance of the nanoparticle size
regarding cytotoxicity (MTS, LDH) and inflammatory
responses (IL-8), whereat the smaller the size of the nano-
particle is, the more harmful are the effects. All different aSNP
sizes have been incorporated in flotillin-1- and flotillin-2-
labelled vesicles in lung epithelial and endothelial cells, which
display a marker for late endosomal or lysosomal structures
and appear to exhibit a clathrin- or caveolae-independent
mode of endocytosis. Flotillin-depleted H441 showed a
clearly decreased uptake of aSNPs. Additionally, the viability
of aSNP-exposed cells was reduced in these cells. These
findings indicate a contribution of flotillins in as yet unknown
(clathrin or caveolae-independent) endocytosis mechanisms
and (or) endosomal storage.
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Background
Nanotechnology has made tremendous progress in the last
decade concerning industrial applications of nanoparticles
(NPs) due to their different features compared to the same
material in bulk form (Service 2004). Almost any material
can be used to produce engineered nanoparticles for
industrial purposes (carbon: lubricants, coatings; titanium
dioxide: toothpaste, white paints, sunscreens; silver: textile
coating with antimicrobial properties; Ellsworth et al.
2000; Institute of Nanotechnology 2011). In particular,
amorphous silica nanoparticles (aSNPs) are widely used for
industrial applications. aSNPs are processed in paints and
coatings, photovoltaic systems, tyre compounds or elec-
trical and thermal insulation material (AEROSIL, EVO-
NIK Industries, http://www.aerosil.com).
They are also added to products to which humans have
direct exposure, for example, cosmetics, toothpaste or even
powdered food ingredients to avoid caking (Waters et al.
2009; Borm et al. 2006). Furthermore, aSNPs among others
are considered to be a promising tool to develop drug and
gene carriers purposed for diagnostic and therapeutical
approaches (Liu et al. 2011). In general, nanoparticles are
increasingly gaining attention in biomedical research for
pulmonary delivery of, that is, insulin or calcitonin
(Kawashima et al. 1999; Yamamoto et al. 2005; Zhang et al.
2001). Recent research activity involves the development
of nanovehicles loaded with, for example, anti-asthmatic
drugs (Surti et al. 2008). On the one hand, the lung is an
ideal target organ for drug and gene delivery via nano-
particles for both systemic and local applications (asthma,
COPD, cystic fibrosis) due to its enormous surface area of
ca. 140 m2 and the reduced first-pass metabolism, by which
the concentration of an applied drug is drastically reduced
before reaching the systemic circulation, not to mention the
targeted organ (Hoet et al. 2004; Bailey and Berkland
2009). On the other hand, these characteristics make the
lung an ideal target site for accidently inhaled hazardous
nanoparticles. Hence, attention must be given to possible
health hazards of inhalation of NPs destined for industrial
or biomedical applications or targets. The attention should
not only be focused on cytotoxic effects. Inhaled nano-
particles may cause unwanted inflammatory responses.
What is not known are the exact nature of the cytotoxic
effects. Furthermore, cellular pathways of internalized NPs
and their eventual distribution and localization within the
cells are generally not known. It is known that nanoparticle
deposition in the peripheral lung appears to be size
dependent. Nanosized particulate matter more likely
reaches the deep lung compared to micronsized particles
(Bailey and Berkland 2009). Furthermore, the deposition
efficiencies of different-sized nanoparticles vary for the
different regions of the lung (Oberdorster et al. 2005). The
size of a nanoparticle is regarded as a pivotal characteristic
factor and closely correlates with its surface area. The
surface parameter is regarded as a prevailing factor with
respect to the reactivity and cytotoxicity of the nanoma-
terials (Kreyling et al. 2010).
Numerous studies have shed some light on the toxic
effects of silica nanoparticles in general (Sun et al. 2011;
Nabeshi et al. 2011) or focused on size-dependent toxic
effects of aSNPs (Li et al. 2011; Napierska et al. 2009).
However, size-dependent inflammatory responses caused
by silica nanoparticles are still poorly understood and may
display a more sensitive reaction compared to the standard
cytotoxicity tests. The goal of this study was to further
characterize the toxic effects and uptake of aSNPs. The
cytotoxic effects of different-sized aSNPs, which were
exposed to the human lung epithelial cell line NCI H441
(H441) and the microvascular endothelial cell line ISO-
HAS-1, were examined using the MTS assay, a test for cell
viability and the LDH assay, an assay for membrane
integrity. In addition, studies were done to investigate the
inflammatory responses (IL-8 release) of H441 and ISO-
HAS-1 following treatment with different-sized aSNPs.
Furthermore, cellular uptake and location of different-sized
aSNPs in H441 and ISO-HAS-1 cells was visualized by
means of colocalization experiments via immunofluores-
cent staining of flotillin-1 and flotillin-2, which display a
marker for late endosomal or lysosomal structures and
appear to exhibit a clathrin- or caveolae-independent mode
of endocytosis (Glebov et al. 2006). Finally, we examined
the importance of flotillin-1 and flotillin-2 on cytotoxic
effects and uptake behaviour of aSNPs in flotillin-con-
taining and flotillin-1- and flotillin-2-depleted H441 gen-
erated by siRNA transfection.
Materials and methods
Nanoparticle characterization
Sicastar Red are amorphous silica nanoparticles in aqueous
dispersion with nominal diameters of 30, 70 and 300 nm.
The particles are loaded with a fluorophore, namely Rho-
damine B, which is covalently attached to the SiO2 matrix.
Sicastar Red is commercially available from micromod
Partikeltechnologie GmbH (www.micromod.de). The samples
were characterized by angular-dependent dynamic light
scattering measurements as described previously (Kasper
et al. 2011).
In pure aqueous solution, Sicastar Red particles with the
nominal diameter of 30 nm showed a hydrodynamic radius
Rh of 12.6 nm (corresponding diameter: 25.2 nm; see
Table 1), indicating that the particles are in a non-aggre-
gated primary particle state. However, in salt-containing
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buffer solution such as PBS and in serum-free cell culture
medium RPMI, these dispersions got destabilized and the
particles partly agglomerated: The average hydrodynamic
radius in PBS is around 66 and 58 nm in RPMI. Simulta-
neously, the l2 values, representing the width of the par-
ticle size distribution and thus being a measure for the
samples polydispersity, also increased. This leads to the
assumption that—despite the increased average hydrody-
namic radii—there is still some non-agglomerated material
left in the dispersion.
Contrary to this observation, Sicastar Red with nominal
diameters of 70 and 300 nm showed sizes similar to the
nominal ones in all aqueous media (i.e. in RPMI: 31.6 nm
for the 70 nm aSNP and 151 nm for the 300 nm aSNP).
Also, the size distributions of these two particles are very
narrow in all cases, even close to true monodispersity, that
is, l2 = 0.03 for Sicastar 70 nm and l2 = 0.04 for Sicastar
300 nm, both in RPMI (samples with l2 values \ 0.05 are
generally considered as monodisperse). Thus, the tendency
to form aggregates is limited to the smallest particles in this
study. Figure 1 depicts the Sicastar nanoparticles in dry
state via TEM (transmission electron microscopy). TEM
revealed similar radii of the aSNPs as obtained via DLS
(Sicastar 30: R = 11.7 ± 1.7 nm (±14.3 %), Sicastar 70:
R = 32.3 ± 4.1 nm (±12.6 %), Sicastar 300: R = 163.7 ±
11.2 nm (±6.9 %). Scale bar = 100 nm).
Cell culture and nanoparticle exposure
Cell culture
ISO-HAS-1 (human microvascular endothelial cell line,
(Masuzawa et al. 1999; Unger et al. 2002)) and NCI H441
(human lung adenocarcinoma cell line, purchased from
ATCC, ATCC-HTB-174, Promochem, Wesel, Germany)
were kept in RPMI 1640 supplemented with 10 % FCS
(foetal calf serum), 1 % P/S (Penicillin/Streptomycin).
ISO-HAS-1 and H441 were passaged every third day in a
dilution of 1:3 until passage 50 and 35, respectively.
Monocultures in experimental procedures
Prior to seeding cells, the 96-well plates (TPP, Switzer-
land) or 8-well l-slides (ibidi) were coated with 50/300 ll
fibronectin for 1 h at 37 C (5 lg/ml, Roche Diagnostics,
Mannheim). The cells were seeded (ISO-HAS-1: 1.6 9 104
Table 1 Characterization of fluorescence-labelled, silica-based nanoparticles
Water PBS RPMI
Rh/nm l2 (90) Rh/nm l2 (90) Rh/nm l2 (90)
Sicastar Red, 30 nm 12.6 0.10 66.2 0.16 58.1 0.17
Sicastar Red, 70 nm 33.2 0.06 34.1 0.03 31.6 0.03
Sicastar Red, 300 nm 157 0.02 151 0.01 151 0.04
Hydrodynamic radii (Rh, with l2 values as an estimate for the polydispersity) in different aqueous solutions (Milli-Q water, phosphate buffered
saline (PBS, without Ca2? and Mg2?) and serum-free cell culture medium RPMI) were obtained by dynamic light scattering (angular-dependent
measurements)
Fig. 1 Electron microscopical image of the Sicastar nanoparticles in
dry state. The fact that the size of the nanoparticles in the dry state
(DTEM) was nearly the same as in solution indicates that the effect of
particle shrinking during the preparation of the samples for TEM is
minimal. Sicastar 30: R = 11.7 ± 1.7 nm (±14.3 %), Sicastar 70:
R = 32.3 ± 4.1 nm (±12.6 %), Sicastar 300: R = 163.7 ± 11.2 nm
(±6.9 %). Scale bar 100 nm
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cells/well, H441: 3.2 9 104 cells/well) from a confluent
culture flask on 96-well plates in RPMI 1640 medium
(Gibco) with L-glutamine supplemented with 10 % FCS
and Pen/Strep (100 U/100 lg/ml) and cultivated at 37 C,
5 % CO2 for 24 h prior to NP exposure to a confluent cell
layer.
Nanoparticle application on cell culture
To prevent nanoparticle aggregation, pre-dilutions of the
NP dispersions were prepared in pure water (Braun ad
injectabilia, Braun Melsungen AG, Melsungen). Due to
nanoparticle aggregation in serum-containing medium,
serum-free medium was used during 4-h exposure. All
dilutions were applied 1:10 in serum-free medium to the
cells (96 well and transwells: 10 ll NP dispersion ? 90 ll
serum-free medium, and ibidi wells: 30 ll NP disper-
sion ? 270 ll serum-free medium). To study cytotoxicity
and inflammatory responses, an exposure time of 4 and 4 h/
20 h (after 4-h incubation, cells were washed twice with
serum-free medium and further cultivated for 20-h period
under normal culture condition) was chosen. For colocal-
ization studies, an exposure time of 20 min, 4 and 4 h/20 h
was chosen.
Cytotoxicity
The viability of the cells was determined using the
CellTiter 96 AQueous One Solution Cell Proliferation
Assay (MTS, Promega, G3582). After nanoparticle incu-
bation, medium was removed and cells were washed twice
with PBS to remove nanoparticle remnants, which can
interfere with the MTS reagent. The MTS reagent (MTS
stock solution mixed with medium in a ratio of 1:10) was
applied on the cell layer for 45 min and transferred into a
new plate to measure OD at 492 nm.
Membrane integrity
25 ll of the supernatant, collected from nanoparticle
exposed H441 and ISO-HAS-1, was used in the LDH
CytoTox 96 Non-Radioactive Cytotoxicity Assay (Pro-
mega, G1780) to determine lactate dehydrogenase (LDH)
release following membrane disruption. To avoid false-
positive results in the LDH assay after 4-h exposure, the
percentage due to aSNP interferences with the dye has been
subtracted from the measurements (i.e. Sicastar Red,
30 nm with 600 lg/ml: 9.8 ± 1.9 % of lysis control).
Inflammatory responses
The supernatant of nanoparticle exposed H441 was taken
to determine IL-8 release via ELISA (DuoSet R&D,
DY208) following the manufacturer0s recommendations.
Immunofluorescence (IF) was performed to label endo-
somal marker proteins flotillin-1 and flotillin-2 (BD,
610821, 610383). After nanoparticle exposure, cells were
fixed with methanol/ethanol (endosomal markers) in a ratio
of 2:1 for 15 min at room temperature. After fixation, cells
were incubated with primary antibody diluted in 1 %
PBSA (phosphate buffered saline with 1 % bovine serum
albumin) over night at 4 C. After three washing steps with
PBS, cells were incubated with secondary antibody (Alexa
Fluor 488) for 1 h at room temperature. Subsequently, cells
were washed three times with PBS and nuclei were stained
with Hoechst 33342 (Molecular Probes) for 5 min and
washed three times. Finally, ibidi l-slides were mounted
with ibidi mounting medium (ibidi, Martinsried).
Transfection of H441 with siRNA
siRNAs were purchased from Ambion (Applied Biosys-
tems: Flotillin-1: s19914 (GCAUCAGUGUGGUUAGCU
Att) and Flotillin-2: s5286 (GACUAUAAACAGUACGU
GUtt). To prepare the siRNA transfection mixture, siRNA
was diluted in serum-free medium and added to the same
volume of Gencarrier-1-mix (Gencarrier-1 stock solution
diluted 1:25 in serum-free medium) and incubated for
30 min at RT. The final siRNA concentration in the well
was 50 nM. The transfection was conducted in parallel to
the seeding of cells on tissue culture plastic (TPP). 5 9 105
(6-well plates) or 3 9 104 (96-well plates) cells were
seeded in 800 ll (6-well plates) or 40 ll (96-well plates) of
low-serum medium (RPMI with 1 % FCS) into a well and
siRNA transfection mixture (200 ll for 6-well plates and
10 ll for 96-well plates) has been applied to the cells
dropwise and mixed thoroughly. After 7 h of incubation at
37 C and 5 % CO2, 1 ml (50 ll) of high-serum medium
(20 % FCS) was added and the cell culture has been con-
tinued for further 17 h. After 24 h, the transfection medium
was replaced by normal culture medium and the cells were
cultured for further 48–72 h to achieve the highest siRNA-
inhibition efficiency. Inhibition efficiency of the siRNA
was checked via real-time PCR (Power SYBR Green
PCR Master Mix, Applied Biosystems, 436765, Real time
PCR machine: 7300 Real Time PCR System, AB). RNA
isolation was conducted by means of the RNeasy Mini Kit
(Qiagen, 74104) following the manufacturer0s protocol.
Reverse transcription of the RNA was performed using
the Omniscript Reverse Transcriptase-System (Qiagen,
205113).
Statistical analysis
From several independent measurements, means and
standard deviations were calculated. Analyses are shown as
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mean ± SD from at least three separate experiments.
Testing for significant differences between means was
carried out using one-way ANOVA and Dunnett’s multiple
comparison test at a probability of error of 5 % (*), 1 %
(**) and 0.1 % (***) or two-way ANOVA with Bonfer-
roni0s post-test.
Results
Cytotoxicity and inflammatory responses
Figure 2a depicts the viability of H441 and ISO-HAS-1 in
conventional monoculture after exposure to different-sized
aSNPs (Sicastar Red with nominal diameters of 30, 70 and
300 nm, as stated by the supplier) with an incubation period
of 4 h at a concentration range of 6, 60, 150, 300, 600 lg/ml
(which is consistent with 6.9 9 109; 6.9 9 1010; 1.8 9 1011;
3.6 9 1011; 6.9 9 1011 lg/cm2) in a volume of 100 ll/well.
For both cell lines, significant differences in cytotoxic effects
between the three different-sized aSNP were observed
(concentration of NPs 150 lg/ml). 30 nm-sized aSNPs
caused a reduced viability in H441 (77 ± 13 % of untreated
control) compared to the larger-sized aSNPs of 70 and
300 nm, which did not show a significant cytotoxic effect
(70 nm: 90 ± 15 %, 300 nm: 96 ± 10 % of untreated con-
trol). Higher concentrations (300 and 600 lg/ml) illustrate a
clearly increased toxicity of the smaller-sized aSNPs of
30 nm (300 lg/ml: 23 ± 6 %, 600 lg/ml 6.5 ± 2 %) com-
pared to the larger-sized aSNPs of 70 nm (300 lg/ml:
88 ± 18 %, 600 lg/ml: 82 ± 20 %) and 300 nm (300 lg/
ml: 102 ± 7 %, 600 lg/ml: 102 ± 11 %). Figure 2b illus-
trates the LDH release after exposure to different-sized
aSNPs (Sicastar Red 30 nm, 70 nm, 300 nm) with an incu-
bation period of 4 h. In H441, LDH leakage occurred for the
30 nm aSNP at a concentration of 60 lg/ml (41 ± 12 % of
lysis control) and reached a peak value at an aSNP concen-
tration of 150 lg/ml (128 ± 16 % of lysis control). For
70 nm aSNPs, however, a marginal but still significant LDH
leakage was observed at a concentration of 150 lg/ml
(32 ± 14 % of lysis control) and the leakage increased with
augmented aSNP concentration and reached a total value at
600 lg/ml (119 ± 11 % of lysis control). Incubation with
300 nm aSNPs resulted in a marginal LDH release at a
concentration of 600 lg/ml (35 ± 9 % of lysis control).
Lower concentrations (300–0.6 lg/ml) did not have an effect
on membrane integrity. ISO-HAS-1 showed a similar
behaviour concerning MTS and LDH as the H441 after aSNP
stimulation, whereat the 30 nm aSNPs caused a decreased
viability (52 ± 13 % of untreated control) and an increased
membrane integrity (84 ± 29 % of lysis control) at a con-
centration of 150 lg/ml. However, the larger-sized aSNPs
(70 nm) showed a reduced viability (300 lg/ml: 75 ± 12.5 %
and 600 lg/ml: 47 ± 8.2 % of untreated control) and an
increased LDH release (300 lg/ml; 66 ± 12 % and 600
lg/ml: 82 ± 16 %) at higher concentrations. 300 nm aSNP
did not show any significantly altered behaviour compared to
the untreated control concerning MTS and LDH even at very
high concentration (600 lg/ml).
In Fig. 3, the IL-8 release after 20 h further cultivation
of the cells, which were exposed to aSNPs for 4 h, is
illustrated. The small-sized aSNPs (30 nm) caused the first
peak at a concentration of 60 lg/ml (Fig. 3a, H441:
2.5 ± 0.5 and Fig. 3b, ISO-HAS-1: 2.9 ± 0.39-fold of
untreated control, uc) whereas bigger-sized aSNP (70 nm)
caused IL-8 release not until a concentration of 150 lg/ml
(H441: 2.3 ± 0.58 and ISO-HAS-1: 3 ± 0.48-fold of uc).
300 nm aSNPs resulted in an IL-8 response not until a
concentration of 300 lg/ml (H441: 1.6 ± 0.59 and ISO-
HAS-1: 2.1 ± 0.32-fold of uc), whereat no effects could be
observed for the cytotoxicity assays (MTS, LDH) even
with 600 lg/ml. For the 30 nm aSNPs, the IL-8 release is
decreasing (i.e. 600 lg for H441: 0.47 ± 0.2 % and ISO-
HAS-1: 1 ± 0.17-fold of uc) with increasing aSNP con-
centration from 60 lg/ml.
Cellular uptake of different-sized aSNPs
Figure 4 depicts the uptake and colocalization with flotil-
lin-1/2-containing vesicles of different-sized aSNPs (30,
70, 300 nm). aSNPs of all sizes are incorporated in flotil-
lin-1/2 vesicles.
aSNP exposure on flotillin-1- and flotillin-2-depleted
cells
Transfection efficiency was determined via real-time PCR. After
4 days, the flotillin-1 and flotillin-2 RNA amount was deter-
mined. Real-time PCR revealed a flotillin-1/2 RNA reduction to
32 ± 9 % P\0.01 for flotillin-1 and 31 ± 6 % (P\0.01)
for flotillin-2 (compared to untransfected control), whereas
the negative control (neg) remained unaffected (flotillin-1:
126 ± 17 % and flotillin-2: 93 ± 15 %, P[0.05). In addition,
the fluorescence signal of immunofluorescence-labelled flotillin-
1/2 decreased in flotillin-1/2-depleted cells compared to the
untransfected cells (see fluorescence signals in Fig. 7). Subse-
quently and prior to experiments with NPs, cytotoxicity of the
transfection procedure was determined via MTS. The viability of
cells was not significantly affected after negative (92 ± 16 %
of untransfected control uc) and flotillin-1/2 (90 ± 18 % of
untransfected control) siRNA treatment. Four days after the
transfection of H441 cells on 96-well plates with siRNA, cells
reached a confluent growth and aSNPs (Sicastar Red) were
applied to the cells for 4 h in serum-free medium and 4 h fol-
lowed by 20-h recovery in fresh FCS-containing medium.
Concentrations of aSNP ranged from 6 to 300 lg/ml.
Arch Toxicol (2013) 87:1053–1065 1057
123
After 4 h of aSNP exposure, untransfected H441
showed a significantly decreased viability (78 ± 6.8 % of
untreated control) following Sicastar Red (30 nm) expo-
sure at a concentration of 60 lg/ml (see Fig. 5). Viability
further decreased with increasing concentration, and at a
concentration of 300 lg/ml, a viability of 66 ± 5.5 % was
observed, compared to the untreated control. After a 20-h
incubation period with fresh FCS-containing medium, the
H441 exposed to 60 lg/ml aSNP ‘‘recovered’’ and no
significant toxic effect (95 ± 14 %) was detected.
Fig. 2 a Viability (MTS assay) of H441 following aSNP treatment
for 4 h in serum-free medium with different-sized Sicastar Red (30,
70, 300 nm). b Lactate dehydrogenase release (LDH) of H441
following aSNP treatment for 4 h with different-sized Sicastar Red
(30, 70, 300 nm). Data are depicted as mean ± SD of 3 independent
experiments with n = 3 samples for each treatment. For statistical
analysis, two-way ANOVA with Bonferroni0s post-test was applied.
*P \ 0.05, **P \ 0.01 and ***P \ 0.001 compared to the untreated
control (uc). 30 nm-sized aSNPs caused a reduced viability and an
increased LDH release in H441 compared to the larger-sized aSNPs
of 70 and 300 nm
Fig. 3 The release of IL-8 was
measured after aSNP (Sicastar
Red, 30 nm: dark grey, 70 nm:
middle grey, 300 nm light grey)
exposure of monocultures of
H441 (a) and ISO-HAS-1 (b) on
96-well plates. After 4-h
incubation in serum-free
medium, aSNPs were removed
and the cells were cultivated for
further 20 h in serum-
containing medium and assayed
for IL-8 release. Data are
depicted as mean ± SD of 2–3
independent experiments with
n = 3 samples for each
treatment. *P \ 0.05,
**P \ 0.01 and ***P \ 0.001
compared to the untreated
control. 30 nm-sized aSNPs
caused an IL-8 response at
lower aSNP concentrations in
H441 and ISO-HAS-1
compared to the larger-sized
aSNPs of 70 and 300 nm
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Concentrations of 100 lg/ml aSNP displayed a similar
effect compared to 4-h exposure (76 ± 13 vs. 73 ± 9.9 %),
whereas 300 lg/ml aSNP elicited a further decline in
viability (28 ± 8.8 %). Comparing the viability of
untransfected and transfected cells after Sicastar Red
exposure, differences were detected in a concentration
Fig. 4 Uptake studies of immunofluorescently (green signal: flotillin
1/2) stained H441 and ISO-HAS-1 kept in conventional monoculture
and exposed to Sicastar Red at a concentration of 60 lg/ml (30, 70,
300 nm) for 4 h and further 20-h cultivation (red signal). A clear
incorporation of NPs in flotillin-1- and flotillin-2-containing vesicles
(green signal) could be detected for all NP sizes. Nuclei are stained
using Hoechst 33342 (blue). Colocalization of different-sized aSNPs
in flotillin-1/2-containing vesicles occurred for all NP sizes. Scale bar
5 lm
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range of 6–300 lg/ml. The non-targeted siRNA (neg) did
not show any alterations compared to the untransfected
cells concerning cytotoxicity after aSNP exposure. More-
over, after an incubation time of 4 h, no significant dif-
ferences between untransfected and flotillin-1/2-depleted
(F12) aSNP-exposed cells were found. Nevertheless, after
the 20-h recovery period, low, subtoxic concentrations of
aSNPs, 6 and 60 lg/ml, showed significant variances dis-
playing a reduced viability of flotillin-1/2-depleted cells
compared to untransfected cells (see red asterisks in
Fig. 5). Figure 6 displays the IL-8 release of flotillin-1/-2-
depleted and aSNP-exposed H441 for 4 h with further 20-h
cultivation in fresh medium. An aSNP concentration of
100 lg/ml resulted in a significant IL-8 release for the
untransfected control group (2.55 ± 0.24-fold of untreated
control with P \ 0.0001 within the untransfected control
group using one-way ANOVA). For the siRNA-transfected
cells, an IL-8 peak could also be detected at a concentration
of 100 lg/ml (neg: 1.75 ± 0.18 and F12: 2 ± 0.33-fold of
untreated control), but for neg significantly lower com-
pared to the peak for the untransfected control group
(P \ 0.01) and for F12 with an increased standard devia-
tion (0.33). Surprisingly, flotillin-1/2-depleted cells took up
less aSNP (Sicastar Red) than untransfected cells according
to visual assessment of images taken by a fluorescence
microscope (Fig. 7). In order to obtain more specific evi-
dence of these findings, the uptake of Sicastar Red was
quantified. Since the concentrations of 6 and 60 lg/ml
were too low to determine the amount of aSNPs taken up
by H441 by spectrophotometric analysis, the quantification
of internalized aSNP by H441 was conducted by means of
intensity measurements of images made by a wide-field
fluorescence microscope (personalDV, Applied Precision,
Issaquah, USA). In Fig. 8 A, the relative fluorescent unit
(RFU: related to the untreated control = 1) was deter-
mined for the fluorescence signal of Sicastar Red, which
was incubated at a concentration of 6 lg/ml with H441 in
conventional monoculture. Non-targeted siRNA showed a
minor, non-significant reduction of fluorescence intensity
(neg: 0.64 ± 0.17 %) of incorporated Sicastar incubated
for 4 h followed by 20-h recovery in fresh medium.
Flotillin-1/2-depleted cells, however, showed a significant
decrease of internalized aSNPs according to RFU mea-
surements (flotillin 1/2: 0.38 ± 0.13 %) (see Fig. 8b).
Furthermore, quantification studies have been conducted
via immunofluorescent staining for flotillin-1/2. RFU
measurements of immunofluorescent staining against flo-
tillin-1/2 revealed a significant reduction of flotillin-1
(0.38 ± 0.27 %) and flotillin-2 (0.28 ± 0.1 %) fluores-
cence signal in flotillin-1/2-depleted H441 cells (Fig. 8a).
Non-targeted siRNA transfection resulted in a minor but
non-significant reduction of fluorescence intensity of flo-
tillin-1 (0.7 ± 0.17 %) and flotillin-2 (0.71 ± 0.24 %). In
summary, flotillin-1/2 depletion results in a reduction of
flotillin-1/2 and a decreased uptake of aSNP. Furthermore,
although a decreased uptake of aSNPs in flotillin-1/2-
depleted cells was detected, an increased toxicity of aSNPs
in flotillin-1/2-depleted cells was found.
Discussion
Using MTT and LDH assays, Napierska et al. (2009) pre-
viously demonstrated a particle size-dependent cytotoxic
Fig. 5 Cytotoxicity (MTS) of flotillin-1- and flotillin-2-depleted
H441 following aSNP treatment with 6–300 lg/ml Sicastar Red
(30 nm). uc untransfected control (no siRNA treatment), neg
Silencer Negative Control #1 siRNA and F12 SilencerSelect
siRNA for flotillin-1 and flotillin-2 in combination (siRNA concen-
tration: 50 nM). Data are depicted as mean ± SD of 3 independent
experiments with n = 3 samples for each treatment. For statistical
analysis, two-way ANOVA with Bonferroni0s post-test was applied.
*P \ 0.05, **P \ 0.01 and ***P \ 0.001 compared to the untreated
control of the respective siRNA pre-treatment. Blue asterisks: ‘‘one-
way ANOVA: within the untransfected control’’, red asterisks: ‘‘two-
way ANOVA: within a concentration of aSNP’’. After 4-h exposure
and 20-h recovery, subtoxic concentrations of 6 and 60 lg/ml Sicastar
Red showed a significantly reduced viability of flotillin-1/2-depleted
cells compared to untransfected cells
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effect in a (supposed) human endothelial cell line
(EAHY926) caused by aSNPs. The results of the present
study corroborate their findings, as in this study the smal-
ler-sized aSNPs (30 nm) were found to cause greater
damage to lung epithelial cells (H441) as determined by the
MTT and LDH assays compared to larger-sized (70,
300 nm) aSNPs. Despite the fact that the 30 nm aSNPs
showed a slight tendency of aggregation, it still displayed a
higher toxicity than larger aSNPs, indicating enough non-
aggregated material, which was also corroborated by the
high polydispersity index (l2 (90) = 0.17). In summary,
cytotoxicity appears to increase with decreasing particle
size. As in Napierska et al. (2009), the dose was expressed
as a mass concentration. Choosing the right dosimetry is a
double-edged sword. Comparing mass concentrations of
different-sized NPs leads to a comparison of different
particle numbers. However, a mass concentration of, for
example, 60 lg/ml (lowest concentration, for which a
cytotoxic effect occurred with 30 nm aSNP) of the 30 nm
aSNP matches with a particle number of 2 9 1012 parti-
cles/ml according to the manufacturer’s specifications,
whereas 60 lg/ml of 300 nm aSNP corresponds to 2 9 109
particles/ml (i.e. 1,0009 less particles compared to 30 nm
aSNP). However, adjusting the 300 nm aSNP to 2 9 1012
particles/ml would lead to a mass concentration of 60 mg/
ml, which is far beyond any physiologically relevant
amount. Additionally, the highest mass concentration of
300 nm that can be applied is 2 9 1011 particles/ml.
However, this particle number corresponds to a mass
concentration of 6 lg/ml for the 30 nm aSNPs, which is
beyond the toxic range of the 30 nm aSNP. Moreover, an
applied dose of 600 lg/ml and also 60 lg/ml does not
simulate realistic exposure conditions as it might occur for,
for example, a ceramic worker. These concentrations may
only occur for accidently inhaled aSNP and were chosen to
display the differences for the different-sized particles.
Lison et al. (2008) considered mass concentration, particle
number, surface area and also the applied volume of NP
dispersion as crucial factors for reliable conclusions on
nanoparticle cytotoxicity. In general, since the smaller the
nanoparticle the bigger the surface area per mass, the
surface area is supposed to be a pivotal factor for the dis-
played biological activity, as reviewed by Oberdo¨rster et al.
(2005).
Inflammatory cytokines such as IL-8 play a pivotal role
in the recruitment and regulation of neutrophils and it has
been shown by other groups to be involved in the NP-
induced inflammatory reaction (Cho et al. 2007; Hetland
et al. 2001). Hefland et al. (2001) also dedicated the
smallest silica NPs as the most potent and correlated the
inflammatory response to the surface area, since the dif-
ferences between different-sized NPs disappeared when
related to equal surface areas. This can be corroborated by
the results of this study, whereat the IL-8 release of aSNP-
exposed cells (H441 and ISO-HAS-1) is increasing with
decreasing particle size (when equal mass concentrations are
compared). Furthermore, this study accentuated analysing
inflammatory responses as the more sensitive method to
examine the harmfulness of nanoparticles compared to cyto-
toxic assays (MTS and LDH), since significant effects could
be observed at aSNP concentrations, where MTS and LDH
have not yet indicated any toxic causes.
Furthermore, uptake pathways such as clathrin- and
caveolae-mediated endocytosis mechanisms have been
investigated via immunofluorescent staining of, for exam-
ple, clathrin heavy chain, EEA1 (Early Endosome Antigen
1) or caveolin 1. However, no definite uptake of aSNPs via
such conventional pathways could be detected (data not
shown). However, all different-sized aSNPs were observed
incorporated in flotillin-1- and flotillin-2-containing vesi-
cles. Flotillin-1 and flotillin-2 are lipid raft proteins (also
called reggie-2 and reggie-1, respectively) and are dis-
cussed to be involved in clathrin- and caveolae-indepen-
dent uptake pathways (Glebov et al. 2006; Ait-Slimane
et al. 2009; Langhorst et al. 2008) or represent a marker for
late/lysosomal compartments (Dermine et al. 2001; Glebov
et al. 2006). Own observations also showed a partly colo-
calization of both flotillins with LAMP1 or cathepsin D in
H441 and ISO-HAS-1 (data not shown).
Since the involvement of flotillins in endocytosis
mechanism can be observed in a variety of cell types such
Fig. 6 IL-8 release of flotillin-1- and flotillin-2-depleted H441
following aSNP treatment with 6-300 lg/ml Sicastar Red (30 nm in
size). uc untransfected control (no siRNA treatment), neg Silencer
Negative Control #1 siRNA and F12 SilencerSelect siRNA for
flotillin-1 and flotillin-2 in combination (siRNA concentration: 50
nM). Data are depicted as mean ± SD of 2 independent experiments
with n = 3 samples for each treatment. For statistical analysis, two-
way ANOVA with Bonferroni0s post-test was applied. *P \ 0.05,
**P \ 0.01 and ***P \ 0.001 compared to the untreated control of
the respective siRNA pre-treatment. Blue asterisks: ‘‘one-way
ANOVA: within the untransfected control’’, red asterisks: ‘‘two-
way ANOVA: within a concentration of aSNP’’
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as macrophages (J774) (Dermine et al. 2001), epithelial
cells (H441 and HeLa (Glebov et al. 2006)) or endothelial
cells (ISO-HAS-1) and an incorporation of nanoparticles of
different sizes (aSNP: 30, 70, 300 nm) or material such as
amorphous silica, organosiloxane particles or poly(ethyl-
eneimine) (further manuscript in preparation), it appears to
be a general phenomenon.
Although recent studies emphasize the size of NPs as a
critical factor for entering the respective uptake pathways
(Vivero-Escoto et al. 2010), in this study the size of aSNPs,
ranging from 30 to 300 nm, was not crucial for targeting
flotillin-1/2-bearing vesicles in H441 and ISO-HAS-1 (see
Fig. 4 for Sicastar Red after 24 h). This supports the
findings of Shapero and co-workers (Shapero et al. 2011),
who detected an aSNP accumulation (50 and 100 nm in
size) in lysosomes of A549 cells after 24 h. The latter
group also found a colocalization of aSNPs with early
endosomes, multilamellar bodies and multivesicular bodies
of A549 cells using electron microscopy, which is a more
sensitive method (due to the higher resolution) to detect
nanosized material than fluorescence-based detection
methods, including immunofluorescence. Besides the size
Fig. 7 a Fluorescence signal of Sicastar Red (30 nm in size, 6 lg/ml)
exposed to H441 (uc untransfected, neg non-targeted siRNA, F12
siRNA against flotillin-1/2) in conventional monoculture for 4 h in
serum-free medium with further 20-h cultivation in fresh serum-
containing medium. Furthermore, transfected H441 were stained via
immunofluorescence for flotillin-1 (b) and flotillin-2 (c). Pictures
were taken by means of a fluorescence microscope (DeltaVision,
Applied Precision). For appropriate comparison, exposure time and
intensity scale was equally adjusted. Flotillin-1/2-depleted cells take-
up less Sicastar Red than non-targeted siRNA and untransfected cells.
Nuclei are stained using Hoechst 33342 (blue), scale bar 5 lm
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dependency, other factors may also play a crucial role
concerning cellular uptake behaviour. On the one hand, a
defined surface coating of the nanoparticle is decisive,
which is already indicated by several studies focussing on
an enhanced uptake and retention of drugs meant for, for
example, systemic or asthma treatment using surface-
modified nanovehicles (Yamamoto et al. 2005; Surti et al.
2008). On the other hand, nanoparticles, which are dis-
persed in protein-containing cell culture media, may adsorb
proteins at the surface and form a protein corona, which is
recognized by the cell despite of the NP itself (Walkey and
Chan 2011).
A depletion/reduction of flotillin-1 and flotillin-2
expression in flotillin-1/2 siRNA-treated H441 cells was
confirmed by real-time PCR studies. Furthermore, the
fluorescence intensity of the immunofluorescent staining of
flotillin-1/2 revealed a significant reduction of flotillin-1/2-
containing vesicles in flotillin-1/2-depleted H441 cells. In
this study, quantification of flotillin-1/2-depleted H441
cells showed a reduced uptake of Sicastar Red compared to
non-transfected control cells. This finding may indicate an
involvement of flotillin-1/2 in the uptake mechanisms of
Sicastar Red. The control cells, which were transfected
with Silencer Negative siRNA (neg), also displayed a
slight, but not significant reduction of the fluorescence
intensity of the aSNP fluorescence signal. Real-time PCR
results, however, did not indicate any reduction of flotillin-
1/2 expression in non-targeted siRNA-transfected H441.
Due to the fact that the transfection procedure using Gen-
carrier-1, which is a lipoplex-based transfection reagent,
may influence endocytosis metabolism, since the lipo-
plexes follow the clathrin-dependent endocytosis route,
non-specific alterations in uptake of aSNPs may be
explainable on the basis of these pre-treatments. For this
reason, it is essential to carry out appropriate control
experiments to verify non-specific influences of pre-treat-
ments, such as transfection reagents.
The mechanisms by which aSNPs exert their cytotoxic
effect are still largely unknown. However, there are many
possibilities, including damage to the plasma membrane
before particles penetrate the cells, intracellular interfer-
ence after uptake in late or lysosomal structures, and
lysosomal escape. Therefore, further experiments were
conducted to obtain more insight into these possible path-
ways. Cytotoxicity of flotillin-1/2-depleted H441 following
aSNP (Sicastar Red) exposure was evaluated and compared
to non-depleted cells. The toxic influence of aSNPs
(Sicastar Red) at low concentrations (6–60 lg/ml) was
increased in flotillin-1/2-depleted cells. After 4 h, a similar
toxicity was observed for non-transfected, aSNP-treated
cells and flotillin-1/2-depleted, aSNP-treated cells. How-
ever, after 20 h of recovery, differences between treat-
ments became evident. While non-transfected cells appear
to recover at low concentrations (6–60 lg/ml) within 20 h
after exposure, the toxic effects of aSNPs persisted in flo-
tillin-1/2-depleted cells. For higher aSNP concentrations
(300 lg/ml), similar toxicity was observed for all cellular
treatments and time-points. Taking the results of Sicastar
Red uptake in flotillin-1/2-depleted H441 into account,
which indicated a decelerated uptake of aSNP as seen by
decreased fluorescence intensity values, an increase in
cytotoxicity appears at first sight to be contradictory.
Assuming an involvement of flotillins in at least storage/
degradation processes, which is corroborated by the
localization of NPs in flotillin-1/2-containing vesicles, even
lower concentrations of incorporated aSNP might display
higher cytotoxicity in flotillin-1/2-depleted cells compared
to the higher amount taken up by the control cells (non-
transfected). Glebov et al. also studied the flotillin-depen-
dent endocytosis mechanism by applying several inhibition
Fig. 8 Determination of RFU (relative fluorescent unit related to
untransfected control cells) a Immunofluorescent staining (IF) for
flotillin-1/2 and subsequent RFU measurement. Data are depicted as
mean ± SD of 2 independent experiments with n = 5 images.
b uptake quantification of aSNP Sicastar Red (6 lg/ml) in H441
(uc untransfected, neg treated with non-targeted siRNA, F12 Flotillin-
1/2-depleted cells). Exposure time: 4 h with further cultivation for
20 h in fresh medium. For statistical analysis, one-way ANOVA with
Dunnett0s multiple comparison test was applied with *P \ 0.05,
**P \ 0.01 and ***P \ 0.00. Flotillin-1/2-depleted cells showed a
significant reduction of flotillin-1 and flotillin-2 fluorescence signal
and a decreased internalization of Sicastar Red compared to non-
targeted siRNA and untransfected cells
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methods (Damke et al. 1995; Glebov et al. 2006). They
stressed the need for careful interpretation of results that
are obtained from such inhibition experiments, since evi-
dence already exists that by inhibiting a distinct endocy-
tosis pathway, another pathway may compensate instead
(Damke et al. 1995). A variety of controls have to be
carried out in order to minimize other possible interpreta-
tions. This is also shown in this study, where the control
group, which where transfected with Silencer Negative
siRNA, concomitant with the flotillin-1/-2 depleted cells,
resulted in a significantly reduced IL-8 response after aSNP
treatment compared to the untransfected, aSNP-exposed
control. To approach more realistic the in vivo situation, it
would be recommendable to reproduce this study with the
multicellular coculture model of the alveolar-capillary
barrier consisting of H441 on top and microvascular
endothelial cells (ISO-HAS-1), which already has been
used to study nanoparticle interactions (Hermanns et al.
2010; Kasper et al. 2011). However, since the H441 in
coculture displays a very tight barrier with well-developed
tight junctions, it is challenging to yield an efficient siRNA
transfection rate, which is also shown by Hermanns et al.
(2010).
In summary, this study attenuates the relevance of the
nanoparticle size regarding cytotoxicity and inflammatory
responses, whereat the smaller the size of the nanoparticle
is, the more potent it causes harmful effects. Furthermore,
all different aSNPs sizes have been incorporated in flotil-
lin-1- and flotillin-2-labelled vesicles in lung epithelial and
endothelial cells, which display a marker for late endo-
somal or lysosomal structures and appear to exhibit a
clathrin- or caveolae-independent mode of endocytosis.
Flotillin-depleted epithelial cells showed a clearly decreased
uptake of aSNPs. Additionally, the viability of cells after
aSNP exposure was reduced in these cells. These findings
indicate a contribution of flotillins in as yet unknown
(clathrin or caveolae independent) endocytosis mechanisms
and (or) endosomal storage.
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